16 results
425
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Business combination disclosure
9:09am
or easements (including conservation easements and public trust easements, rights-of-way, road use Contracts, covenants, conditions, restrictions
8-K
EX-2.1
LGND
Ligand Pharmaceuticals, Inc. - Ordinary Shares
24 Mar 22
Entry into a Material Definitive Agreement
9:08am
or measurement, rights of parties in possession, servitudes or easements (including conservation easements and public trust easements, rights-of-way, road
8-K
EX-99.1
t594auy2rb3w6aah uwp
20 Oct 20
Results of Operations and Financial Condition
10:52am
8-K
EX-10.1
rs63rb
10 Sep 20
Entry into a Material Definitive Agreement
4:43pm
8-K
EX-4.1
xig9udnl 6xiv
22 May 18
Entry into a Material Definitive Agreement
5:12pm
8-K
EX-10.1
wtzngyy6sio2zc8q402y
9 Sep 11
Entry into a Material Definitive Agreement
12:00am
8-K
EX-10.1
ofiuievhq5q
19 Dec 07
Entry into a Material Definitive Agreement
12:00am
424B3
6cnvbyfn6ehk285v
1 Nov 06
Prospectus supplement
12:00am
8-K
EX-10.1
j21j7
31 Oct 06
Entry into a Material Definitive Agreement
12:00am
S-4
EX-2.1
x1un5 slitek
9 Jul 98
Registration of securities issued in business combination transactions
12:00am
- Prev
- 1
- Next